title: Beta-cell response and insulin hepatic extraction in noncirrhotic alcoholic patients soon after withdrawal.
abstract: A decreased tolerance to carbohydrates has been reported in several studies of liver diseases, whereas only a few investigations have been performed in chronic noncirrhotic alcoholic patients with and without alcohol abstinence. The aim of this study was to evaluate in detail the metabolic portrait of six noncirrhotic alcoholics during the early phase of alcohol withdrawal by quantifying the main processes involved in glucose disappearance. Data from frequently sampled intravenous glucose tolerance tests (FSIGTs) were analyzed by means of the minimal model (MINMOD) approach, which provided measurements of the (prehepatic) beta-cell secretion and of insulin degradation in the liver, along with indexes of insulin sensitivity and glucose effectiveness. Plasma insulin levels were lower in the patients (basal, 3.5 +/- 0.2 v 8.0 +/- 1.8 in matching controls, P < .05; area under the curve, 1.41 +/- 0.07 mU/mL in 240 minutes v 4.06 +/- 0.37, P < .001), and C-peptide concentrations were higher (basal, 107 +/- 3.5 v 36 +/- 9 ng/dL in controls, P < .05; area under the curve, 492 +/- 118 ng/mL in 240 minutes v 245 +/- 66, P = .05). The model analysis confirmed the absence of a decrease beta-cell release; in fact, in the alcoholics there was a basal secretion of 19 +/- 5 versus 9 +/- 2 pmol/L/min in controls (P < .05) and a total release of 9.5 +/- 1.8 nmol/L in 240 minutes versus 6.5 +/- 1.4.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: 2nd Medical Clinic, Policlinico Umberto I, Università La Sapienza, Rome, Italy.
authors.forename: M G
authors.initials: MG
authors.lastname: Piccardo
authors.forename: G
authors.initials: G
authors.lastname: Pacini
authors.forename: E
authors.initials: E
authors.lastname: Nardi
authors.forename: M S
authors.initials: MS
authors.lastname: Rosa
authors.forename: R
authors.initials: R
authors.lastname: De Vito
mesh_terms: D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000097:blood / Q000503:physiopathology*; D001706:Biopsy; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D000431:Ethanol / Q000009:adverse effects*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000032:analysis* / Q000097:blood / Q000378:metabolism; D007515:Islets of Langerhans / Q000166:cytology* / Q000502:physiology*; D008099:Liver / Q000737:chemistry* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008433:Mathematics; D008875:Middle Aged; D008954:Models, Biological; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D000431:Ethanol